Li Lulu, Jia Chao, Tang Yue, Kong Yuanyuan, Xia Yaofang, Ma Li
Department of Newborn Screening Center, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, Beijing, China.
Department of Neonatology, Hebei Provincial Children's Hospital, Shijiazhuang, China.
Front Pediatr. 2021 Mar 4;9:638190. doi: 10.3389/fped.2021.638190. eCollection 2021.
Congenital insensitivity to pain with anhidrosis (CIPA) is a rare inherited autosomal recessive disorder characterized by insensitivity to noxious stimuli, anhidrosis, recurrent fever, and intellectual disability. CIPA is mainly caused by mutations in the neurotrophic tyrosine kinase receptor type 1 gene (). This study aims to identify pathogenic mutations underlying CIPA in two unrelated Chinese families. DNA was extracted from blood samples of patients and their available family members and subjected to whole exome sequencing (WES). Real-time PCR (qPCR), Gap-PCR, and Sanger sequencing were applied to verify the identified variants. We found novel compound gross deletion mutations [exon1-6 del (g.1-1258_10169del); exon5-7 del (g.6995_11999del)] of (MIM 191315) gene in family 1 and the compound heterozygous mutations [c.851-33T>A; exon5-7 del (g.6995_11999del)] in family 2. Interestingly, we discovered the intragenic novel gross deletion [exon5-7 del (g.6995_11999del)] mediated by recombination between Alu elements. The present study highlights two rare gross deletion mutations in the gene associated with CIPA in two unrelated Chinese families. The deletion of exon1-6 (g.1-1258_10169del) is thought to be the largest deletion reported to date. Our findings expand the mutation spectrum of mutations in the Chinese and could be useful for prenatal interventions and more precise pharmacological treatments to patients. WES conducted in our study is a convenient and useful tool for clinical diagnosis of CIPA and other associated disorders.
先天性无痛觉伴无汗症(CIPA)是一种罕见的常染色体隐性遗传性疾病,其特征为对伤害性刺激不敏感、无汗、反复发热和智力残疾。CIPA主要由神经营养性酪氨酸激酶受体1型基因()的突变引起。本研究旨在鉴定两个无关的中国家庭中CIPA潜在的致病突变。从患者及其可获取的家庭成员的血液样本中提取DNA,并进行全外显子组测序(WES)。应用实时定量聚合酶链反应(qPCR)、缺口聚合酶链反应(Gap-PCR)和桑格测序来验证所鉴定的变异。我们在家庭1中发现了新的复合大片段缺失突变[外显子1 - 6缺失(g.1 - 1258_10169del);外显子5 - 7缺失(g.6995_11999del)],在家庭2中发现了复合杂合突变[c.851 - 33T>A;外显子5 - 7缺失(g.6995_11999del)]。有趣的是,我们发现了由Alu元件之间的重组介导的基因内新的大片段缺失[外显子5 - 7缺失(g.6995_11999del)]。本研究突出了两个无关的中国家庭中与CIPA相关的该基因的两个罕见大片段缺失突变。外显子1 - 6(g.1 - 1258_10169del)的缺失被认为是迄今为止报道的最大的 缺失。我们的发现扩展了中国人中 突变的谱,并且可能对产前干预以及对患者更精确的药物治疗有用。我们研究中进行的WES是用于CIPA和其他相关疾病临床诊断的便捷且有用的工具。